Home

Nyugati Hentes útmutató figo iiic ovarian cancer Hámlás Ideális esetben nevelőszülők

Ovarian cancer
Ovarian cancer

Reprod. Med. | Free Full-Text | Ovarian Cancer: Treatment and Resistance to  Pharmacotherapy
Reprod. Med. | Free Full-Text | Ovarian Cancer: Treatment and Resistance to Pharmacotherapy

Hypoxic isolated abdominal perfusion breaks through chemoresistance in  recurrent FIGO stage IIIC and IV ovarian cancer
Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer

FIGO 2014 Staging of Cancer Ovary
FIGO 2014 Staging of Cancer Ovary

Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment  (PDQ®)–Health Professional Version - NCI
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version - NCI

Overall survival of patients with stage III ovarian cancer according to...  | Download Scientific Diagram
Overall survival of patients with stage III ovarian cancer according to... | Download Scientific Diagram

Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging
Ovarian Cancer, the Revised FIGO Staging System, and the Role of Imaging

Stage 3 ovarian cancer | Cancer Research UK
Stage 3 ovarian cancer | Cancer Research UK

PDF) Should we modify the current FIGO staging system for stage IIIC  ovarian cancer? | Hee-Sug Ryu - Academia.edu
PDF) Should we modify the current FIGO staging system for stage IIIC ovarian cancer? | Hee-Sug Ryu - Academia.edu

Ovarian Cancer Overview: Molecular Biology and Its Potential Clinical  Application | IntechOpen
Ovarian Cancer Overview: Molecular Biology and Its Potential Clinical Application | IntechOpen

PDF] 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. |  Semantic Scholar
PDF] 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. | Semantic Scholar

IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with  Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO  IIIC Serous-Type Tubo-Ovarian Cancer
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer

Patients with stage IV epithelial ovarian cancer: understanding the  determinants of survival | Journal of Translational Medicine | Full Text
Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival | Journal of Translational Medicine | Full Text

Prognostic factors of overall survival for patients with FIGO stage IIIc or  IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by  interval debulking surgery: A multicenter cohort analysis from the  FRANCOGYN study
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study

Patient data for ovarian cancer FIGO IIIc (n = 86) | Download Table
Patient data for ovarian cancer FIGO IIIc (n = 86) | Download Table

Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a  Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking  Surgery
Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery

FIGO staging of ovarian cancer, 2014 [5]. | Download Scientific Diagram
FIGO staging of ovarian cancer, 2014 [5]. | Download Scientific Diagram

Staging for OVFTP malignancies | Figo
Staging for OVFTP malignancies | Figo

FIGO 2014 Staging of Cancer Ovary
FIGO 2014 Staging of Cancer Ovary

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian  tube, or primary peritoneal cancer treatment (ICON8): overall survival  results from an open-label, randomised, controlled, phase 3 trial - The  Lancet Oncology
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial - The Lancet Oncology

FIGO staging of ovarian cancer | Download Table
FIGO staging of ovarian cancer | Download Table

World J Oncol
World J Oncol

Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian  Cancer Treated at a Single Institution | In Vivo
Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution | In Vivo